Close Menu


The offer to acquire Dionex shares for $118.50 per share has been extended to April 7.

The firm has yet to provide an estimated amount of proceeds from the notes offerings, which will help pay for its $2.1 billion acquisition of Dionex.

The company, which is currently being acquired by Thermo Fisher Scientific, recorded a 21-percent rise in HPLC sales driven largely by strong demand in China, said CEO Frank Whitney.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The company, which posted a 9 percent jump in net income, is currently seeking to transfer jurisdiction for the Dionex purchase to the European Commission, rather than file for regulatory approvals in multiple countries, said an official.

With executives from Agilent, Thermo Fisher, Waters, and Danaher presenting this week at the JP Morgan Healthcare Conference, UPLC as well as triple quadrupole and qual-quan mass spec proved primary areas of discussion.

Thermo Fisher extended the offer to buy all outstanding shares of Dionex to Feb. 17.

Thermo said it is in the process of "seeking similar clearances under antitrust laws of other jurisdictions," and expects to complete the acquisition later in the quarter.

The release of a long-awaited protein biomarker test, increased adoption of a major instrument platform, and a pair of proteome mapping milestones marked a year in which several much-anticipated advances in proteomics arrived.

The purchase, which is expected to close in the first quarter of 2011, will add a range of ion and liquid chromatography products to Thermo Fisher's portfolio, including platforms aimed at proteomics research like Dionex's UltiMate 3000 RSLCnano LC system.


Politico notes that the Biden Administration has not yet nominated a permanent Food and Drug Administration commissioner. 

Anthony Fauci also informed the World Health Organization executive board that the US would be joining the COVAX initiative, according to CNBC.

A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.

In Nature this week: Australian lungfish provides details on the movement of vertebrate life from water to land, and more.